文献速递银屑病与炎症性皮肤病

无肌肉骨骼受累的银屑病患者亚临床滑膜炎:系统评价与荟萃分析

Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Dermatol · 2025-01-01

结果显示银屑病患者亚临床滑膜炎风险为健康对照的2.55倍(RR,95%CI 1.18-5.52),MRI检出率高于超声。银屑病关节炎患者滑膜炎更常见但差异无统计学意义。

要点

  • 无肌肉骨骼受累的银屑病患者亚临床滑膜炎风险显著高于健康对照(RR 2.55)。
  • MRI对亚临床滑膜炎的检出风险比高于超声(RR 6.40 vs 2.50)。
  • 影像学或有助于识别进展为银屑病关节炎的高风险银屑病患者。

核心结论

  • 无肌肉骨骼受累的银屑病患者亚临床滑膜炎患病率显著高于健康对照。
  • 影像学可能有助于识别进展为银屑病关节炎的高风险个体。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、Embase、Scopus和Web of Science至2024年10月。
  • 采用随机效应模型合并风险比(RR),使用I2统计量评估异质性,Newcastle-Ottawa量表评估偏倚风险。

主要发现

  • 银屑病患者发生滑膜炎的风险为健康对照的2.55倍(RR,95%CI 1.18-5.52)。
  • MRI检测的滑膜炎风险比高于超声(MRI RR 6.40,95%CI 1.87-21.95;超声 RR 2.50,95%CI 1.10-5.67)。
  • 银屑病关节炎患者滑膜炎较银屑病患者更常见,但差异无统计学意义(RR 0.50,95%CI 0.13-1.87)。

关键数值与推荐

  • 银屑病患者与健康对照的滑膜炎风险比RR为2.55(95%CI 1.18-5.52)。
  • MRI的RR为6.40(95%CI 1.87-21.95),超声的RR为2.50(95%CI 1.10-5.67)。
  • 银屑病关节炎与银屑病比较的RR为0.50(95%CI 0.13-1.87)。

临床怎么用

  • 对无肌肉骨骼症状的银屑病患者,可考虑影像学筛查亚临床滑膜炎以评估银屑病关节炎风险。
  • MRI对亚临床滑膜炎的检出敏感性可能高于超声。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Psoriasis affects up to 3% of the population, with 30% of patients with psoriasis developing psoriatic arthritis (PsA), yet the transition between psoriasis and PsA has yet to be fully understood. Subclinical synovitis is a hallmark of PsA and is thought to precede psoriatic arthritis; its detection among patients with psoriasis without musculoskeletal (MSK) involvement through medical imaging modalities could offer valuable insights into the transition from psoriasis to PsA. OBJECTIVE: To evaluate the prevalence of synovitis on ultrasonograms and magnetic resonance imaging (MRI) among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA. DATA SOURCES: A comprehensive literature search was conducted in MEDLINE, Embase, Scopus, and Web of Science from inception to October 2024 using keywords related to psoriasis, synovitis, and medical imaging. A PROSPERO protocol was registered (CRD42024571308). STUDY SELECTION: Studies were eligible if they included patients with psoriasis without MSK involvement and assessed synovitis using imaging. Two reviewers independently screened studies and extracted data. Discrepancies were resolved by consensus. Twelve of 5132 initially identified studies met inclusion criteria. DATA EXTRACTION AND SYNTHESIS: Data were extracted per PRISMA guidelines. Risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model was used to pool risk ratios (RRs) for synovitis prevalence across comparison groups. Heterogeneity was assessed using the I2 statistic. MAIN OUTCOMES AND MEASURES: The primary outcome was the presence of imaging-detected synovitis among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA. RESULTS: Twelve studies (N = 2606 patients) were included comprising 1593 patients with psoriasis (mean [SD] age, 46.4 [7.5] years; 982 men [61.6%]), 327 patients with PsA (mean [SD] age, 50.2 [7.1] years; 210 men [64.2%]), and 686 healthy controls (mean [SD] age, 45.7 [6.9] years; 281 of 576 men [48.8%]). Synovitis was 2.5 times more likely among patients with psoriasis than controls (RR, 2.55; 95% CI, 1.18-5.52). Detection rates were higher with MRI (RR, 6.40; 95% CI, 1.87-21.95) than ultrasonography (RR, 2.50; 95% CI, 1.10-5.67). Synovitis was more frequent among patients with PsA than those with psoriasis, but the difference was not statistically significant (RR, 0.50; 95% CI, 0.13-1.87). CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found that subclinical synovitis is significantly more prevalent among patients with psoriasis without MSK involvement compared with healthy controls. This finding suggests that imaging may aid in identifying individuals at risk for progression to psoriatic arthritis.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Mehta S, Xiong G, Metko D, et al. Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2025. PMID: 40668567. doi:10.1001/jamadermatol.2025.2281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。